Stock Yards Bank & Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Stock Yards Bank & Trust's AZN Position: Q2 2026 in Review
Stock Yards Bank & Trust reduced its AstraZeneca (AZN) stake by 3.1% in Q2 2026, selling an estimated $20.7K and leaving 3,484 shares worth $661K. The position accounts for 0.02% of the portfolio, ranked #258.
Stock Yards Bank & Trust first reported a position in AZN in Q2 2022 and has held it in 17 quarters since. The position peaked at $709K in Q1 2026. 1,508 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Stock Yards Bank & Trust held 3,484 shares of AstraZeneca worth $661K as of Q2 2026.
- Stock Yards Bank & Trust sold 110 AstraZeneca shares in Q2 2026, an estimated $20.7K.
- AstraZeneca made up 0.02% of Stock Yards Bank & Trust's portfolio in Q2 2026, its #258 holding.
- Stock Yards Bank & Trust first reported a position in AstraZeneca in Q2 2022 and has held it in 17 quarters since.
- Stock Yards Bank & Trust's AstraZeneca position peaked at $709K in Q1 2026.
- 1,508 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Stock Yards Bank & Trust's 13F filing for Q2 2026, filed 13 Aug 2026.